Northern Trust Corp Scynexis Inc Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Scynexis Inc stock. As of the latest transaction made, Northern Trust Corp holds 137,614 shares of SCYX stock, worth $101,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,614
Previous 153,518
10.36%
Holding current value
$101,834
Previous $176,000
26.14%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SCYX
# of Institutions
46Shares Held
12.2MCall Options Held
0Put Options Held
2K-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.14 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.66 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.23 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$909,3930.26% of portfolio
-
Amh Equity LTD627KShares$464,0070.97% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $24.2M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...